☆ 4.4 Letter

Pharmacokinetic and Clinical Considerations for Monitoring Asparaginase Activity Levels During Pegaspargase Therapy

PEDIATRIC BLOOD & CANCER (2015)

Journal

PEDIATRIC BLOOD & CANCER

Volume 62, Issue 6, Pages 1115-1115

Publisher

WILEY-BLACKWELL

DOI: 10.1002/pbc.25426

Keywords

-

Categories

Oncology Hematology Pediatrics

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.